Literature DB >> 1877681

Vasorelaxant effects of short chain fatty acid salts in rat caudal artery.

C W Nutting1, S Islam, J T Daugirdas.   

Abstract

Acetate relaxes rat caudal artery and increases tissue adenosine 3',5'-cyclic monophosphate (cAMP) levels. The present study's purpose was to determine whether related ultrashort chain (volatile) fatty acids, propionate (C3), butyrate (C4), and octanoate (C8) would do so as well. It was found that butyrate and propionate had very similar vasorelaxant profiles to acetate; they relaxed caudal artery strips precontracted with KCl, phenylephrine, arginine vasopressin, and prostaglandin F2 alpha. The vasorelaxation was endothelium independent, was not blocked by indomethacin, and was associated with a rise in tissue cAMP levels but not in guanosine 3',5'-cyclic monophosphate (cGMP) levels. The mean effective concentration for butyrate (0.8 mM) was lower than that for acetate (2.0 mM) or propionate (1.9 mM). Propionate-mediated relaxation was blocked by the stilbene inhibitor 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid (DIDS). Vasorelaxant effects of octanoate were also not dependent on endothelium and were not affected by indomethacin. Maximal vasorelaxant effect of octanoate was greater than that of acetate, propionate, or butyrate; vasorelaxant effect of octanoate was only slightly attenuated by DIDS and was associated with only a minimal effect on tissue cAMP levels. Results suggest that vasodilatory effects of acetate generalize to propionate and butyrate, but that vasorelaxant effects of octanoate may be occurring via a separate mechanism.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1877681     DOI: 10.1152/ajpheart.1991.261.2.H561

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  37 in total

1.  Inhibition of choline acetyltransferase activity by serum albumin modified with octanoic acid and other fatty acids.

Authors:  Y Ninomiya; Y Kayama
Journal:  Neurochem Res       Date:  1998-10       Impact factor: 3.996

Review 2.  Microbial Short-Chain Fatty Acids and Blood Pressure Regulation.

Authors:  Jennifer L Pluznick
Journal:  Curr Hypertens Rep       Date:  2017-04       Impact factor: 5.369

3.  A novel SCFA receptor, the microbiota, and blood pressure regulation.

Authors:  Jennifer Pluznick
Journal:  Gut Microbes       Date:  2013-12-20

Review 4.  Plant-Based Diets and Hypertension.

Authors:  Shivam Joshi; Leigh Ettinger; Scott E Liebman
Journal:  Am J Lifestyle Med       Date:  2019-09-24

5.  Obstructive Sleep Apnea and Systemic Hypertension: Gut Dysbiosis as the Mediator?

Authors:  Saif Mashaqi; David Gozal
Journal:  J Clin Sleep Med       Date:  2019-10-15       Impact factor: 4.062

Review 6.  Gut Microbial Metabolites and Blood Pressure Regulation: Focus on SCFAs and TMAO.

Authors:  Brian G Poll; Muhammad Umar Cheema; Jennifer L Pluznick
Journal:  Physiology (Bethesda)       Date:  2020-07-01

Review 7.  Short chain fatty acids and methylamines produced by gut microbiota as mediators and markers in the circulatory system.

Authors:  Maksymilian Onyszkiewicz; Kinga Jaworska; Marcin Ufnal
Journal:  Exp Biol Med (Maywood)       Date:  2020-01-16

Review 8.  Beyond gut feelings: how the gut microbiota regulates blood pressure.

Authors:  Francine Z Marques; Charles R Mackay; David M Kaye
Journal:  Nat Rev Cardiol       Date:  2017-08-24       Impact factor: 32.419

9.  Mechanism of butyrate-induced vasorelaxation of rat mesenteric resistance artery.

Authors:  P I Aaronson; W McKinnon; L Poston
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

10.  Microbial short chain fatty acid metabolites lower blood pressure via endothelial G protein-coupled receptor 41.

Authors:  Niranjana Natarajan; Daijiro Hori; Sheila Flavahan; Jochen Steppan; Nicholas A Flavahan; Dan E Berkowitz; Jennifer L Pluznick
Journal:  Physiol Genomics       Date:  2016-09-23       Impact factor: 3.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.